THALIDOMIDE AND LOVASTATIN AS A SALVAGE IMMUNOMODULATORY THERAPY IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA

被引:0
|
作者
Hus, M.
Adamczyk-Cioch, M. [1 ]
Jawniak, D. [1 ]
Grzasko, N. [1 ]
Morawska, M. [1 ]
Kozicka, J. [1 ]
Szostek, M. [2 ]
Helbig, G. [3 ]
机构
[1] Med Univ, Dept Hematol & Bone Marrow Transplantat, Lublin, Poland
[2] Jagiellonian Univ, Coll Med, Dept Haematol, Krakow, Poland
[3] Silesian Med Univ, Katowice, Poland
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1445
引用
收藏
页码:577 / 577
页数:1
相关论文
共 50 条
  • [41] Low-dosed thalidomide regimens in therapy of relapsed or refractory multiple myeloma
    Zemanova, M.
    Scudla, V.
    Pour, L.
    Gregora, E.
    Pavlicek, P.
    Minarik, J.
    Pika, T.
    Bacovsky, J.
    Adam, Z.
    Hajek, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 174 - 174
  • [42] Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma
    Schey, SA
    Fields, P
    Bartlett, JB
    Clarke, IA
    Ashan, G
    Knight, RD
    Streetly, M
    Dalgleish, AG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) : 3269 - 3276
  • [43] Autologous peripheral blood stem transplantation after thalidomide therapy of relapsed/refractory multiple myeloma patients
    Dmoszynska, A.
    Hus, M.
    Grzasko, N.
    Jawniak, D.
    Legiec, W.
    Wach, M.
    Cioch, M.
    Manko, J.
    Walter-Croneck, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S324 - S324
  • [44] THE MAINTENANCE THERAPY WITH THALIDOMIDE IN ELDERLY PATIENTS WITH MULTIPLE MYELOMA
    Bila, J.
    Lekovic, D.
    Smiljanic, M.
    Sretenovic, A.
    Andjelic, B.
    Vidovic, A.
    Todorovic, M.
    Elezovic, I.
    Tomin, D.
    Gotic, M.
    Mihaljevic, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 583 - 583
  • [45] THALIDOMIDE-DEXAMETHASONE (THALDEX) AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS RELAPSING AFTER HIGH DOSE THERAPY AND AUTOPBSCT
    Charlinski, G.
    Barwicka, M.
    Wiater, E.
    Dwilewicz-Trojaczek, J.
    Wiktor-Jedrzejczak, W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 262 - 263
  • [46] Immunomodulatory analogs of thalidomide: An emerging new therapy in myeloma
    Richardson, P
    Anderson, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) : 3212 - 3214
  • [47] Strategies for salvage therapy post CAR-T therapy failure in refractory/relapsed multiple myeloma patients
    Min, Chao
    Zhong, Xiong
    Cui, Yue
    Zhang, Hanfu
    Wang, Qingming
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [48] Salvage second transplantation in relapsed multiple myeloma
    Binod Dhakal
    Anita D’Souza
    Ariel Kleman
    Saurabh Chhabra
    Meera Mohan
    Parameswaran Hari
    Leukemia, 2021, 35 : 1214 - 1217
  • [49] Salvage second transplantation in relapsed multiple myeloma
    Dhakal, Binod
    D'Souza, Anita
    Kleman, Ariel
    Chhabra, Saurabh
    Mohan, Meera
    Hari, Parameswaran
    LEUKEMIA, 2021, 35 (04) : 1214 - 1217
  • [50] Thromboprophylaxis In Multiple Myeloma Patients Undergoing Immunomodulatory Therapy with Thalidomide and Lenalidomide: A Systematic Review and Meta-Analysis
    Carrier, Marc
    Le Gal, Gregoire
    Tay, Jason
    Wu, Cynthia M.
    Lee, Agnes Y.
    BLOOD, 2010, 116 (21) : 475 - 476